Related Experiment Video
Updated: Sep 16, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Left Ventricular Assist Device, Implantable Cardioverter Defibrillator, and Radiation Therapy: A Technical Report,
Alexander Bennassi1, Tony Truong2, Nhu Hanh To1
1Department of Radiation Oncology And Henri Mondor Breast Center, Hôpital Henri Mondor, Créteil, France; Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, i-Biot and University of Paris East Créteil (UPEC), France.
Insights
Managing patients with both implantable cardioverter defibrillators (ICDs) and left ventricular assist devices (LVADs) during radiation therapy (RT) requires careful planning. This case report details considerations for safe RT delivery in patients with advanced cardiac devices.
Area of Science:
- Cardiology
- Radiation Oncology
- Medical Physics
Background:
- Cardiology advancements have improved survival for patients with severe heart conditions requiring implantable cardioverter defibrillators (ICDs) and left ventricular assist devices (LVADs).
- Radiation therapy (RT) is a critical cancer treatment, but its delivery poses challenges for patients with cardiac devices.
- Managing patients with both ICDs and LVADs during RT requires addressing potential device malfunctions and radiation interactions.
Purpose of the Study:
- To present a case of a patient with both a triple-chamber ICD and an electronically equipped LVAD undergoing RT.
- To explore dosimetric considerations and device interactions during RT for patients with advanced cardiac devices.
- To provide recommendations for the safe and effective integration of RT in this patient population.
Main Methods:
- Case report of a patient with a triple-chamber ICD and an electronically equipped LVAD undergoing RT.
- Analysis of dosimetric considerations and potential device interactions.
- Development of adapted simulations to minimize risks associated with RT delivery.
Main Results:
- The study highlights the unique challenges in managing patients with combined ICD and LVAD devices during RT.
- Identified specific risks related to radiation exposure and device function.
- Demonstrated the necessity of adapted simulations and careful planning for RT delivery.
Conclusions:
- Safe and effective RT delivery is achievable in patients with advanced cardiac devices like ICDs and LVADs.
- Careful consideration of dosimetric factors, device interactions, and adapted simulations is crucial.
- This work bridges a knowledge gap, offering recommendations for managing these complex cases.
Abstract:
Recent advancements in cardiology have significantly improved survival and quality of life for patients with severe heart conditions, including those requiring implantable cardioverter defibrillators (ICDs) and left ventricular assist devices (LVADs). Radiation therapy (RT) using either conventional or advanced techniques, such as stereotactic body RT, remains a cornerstone treatment for cancer. However, managing patients with both ICDs and LVADs during RT presents unique challenges caused by potential device malfunctions and interactions with radiation. In this report, we present a case of a patient with both a triple-chamber ICD and an electronically equipped LVAD undergoing RT. The study explores the dosimetric considerations, device interactions, and adapted simulations required to minimize risks. This work aimed to bridge the knowledge gap and provide recommendations for the safe and effective integration of RT delivery in patients with advanced cardiac devices.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease IV: Nursing Management
Heart Failure V: Medical Management

